MicroRNAs in cancer management and their modulation by dietary agents

Biochemical Pharmacology

Volumn 83, Issue 12, 2012, Pages 1591-1601

  Karius, Tommy ^a   Schnekenburger, Michael ^a   Dicato, Mario ^a   Diederich, Marc ^a  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

Author keywords

Biomarker; Cancer; Chemoprevention; Chemotherapy; Dietary agents; microRNA; miRNA inhibitors; miRNA mimics

Indexed keywords

ALPHA TOCOPHEROL; BUTYRIC ACID; CURCUMIN; EPIGALLOCATECHIN GALLATE; FATTY ACID; GENISTEIN; INDOLE DERIVATIVE; MICRORNA; RESVERATROL; RETINOIC ACID; RETINOL; RNA INDUCED SILENCING COMPLEX; SELENIUM; VITAMIN B GROUP; VITAMIN D;

3' UNTRANSLATED REGION; APOPTOSIS; BILE DUCT CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CARCINOGENESIS; CELL AGING; CELL CYCLE REGULATION; CELL METABOLISM; CELL MIGRATION; CHEMOPROPHYLAXIS; CHROMOSOME ABERRATION; COLON CANCER; DIETARY INTAKE; DNA METHYLATION; ESOPHAGUS CANCER; GENE EXPRESSION; LEUKEMIA; LUNG CANCER; MOLECULAR MIMICRY; NEOPLASM; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; REVIEW; SKIN CANCER; STOMACH CANCER; TESTIS CANCER; TISSUE DIFFERENTIATION; VITAMIN SUPPLEMENTATION;

EID: 84860127568     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.02.004     Document Type: Note

References (100)

1. R.C. Lee, R.L. Feinbaum, and V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854
2. P.B. Kwak, S. Iwasaki, and Y. Tomari The microRNA pathway and cancer Cancer Sci 101 2010 2309 2315
3. W. Filipowicz RNAi: the nuts and bolts of the RISC machine Cell 122 2005 17 20
4. J. Liu, M.A. Carmell, F.V. Rivas, C.G. Marsden, J.M. Thomson, and J.J. Song Argonaute2 is the catalytic engine of mammalian RNAi Science 305 2004 1437 1441
5. M.A. Parasramka, E. Ho, D.E. Williams, and R.H. Dashwood MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals Mol Carcinog 51 2011 213 230
6. G. Meister, and T. Tuschl Mechanisms of gene silencing by double-stranded RNA Nature 431 2004 343 349
7. I. Behm-Ansmant, J. Rehwinkel, T. Doerks, A. Stark, P. Bork, and E. Izaurralde mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes Genes Dev 20 2006 1885 1898
8. N. Standart, and R.J. Jackson MicroRNAs repress translation of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation Genes Dev 21 2007 1975 1982
9. A. Eulalio, I. Behm-Ansmant, and E. Izaurralde P bodies: at the crossroads of post-transcriptional pathways Nat Rev Mol Cell Biol 8 2007 9 22
10. L. Ma, J. Teruya-Feldstein, and R.A. Weinberg Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 2007 682 688
11. S.S. Ryazansky, and V.A. Gvozdev Small RNAs and cancerogenesis Biochemistry (Mosc) 73 2008 514 527
12. N. Valeri, I. Vannini, F. Fanini, F. Calore, B. Adair, and M. Fabbri Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation Mamm Genome 20 2009 573 580
13. G.A. Calin, C. Sevignani, C.D. Dumitru, T. Hyslop, E. Noch, and S. Yendamuri Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc Natl Acad Sci U S A 101 2004 2999 3004
14. J.T. Dong, J.C. Boyd, and H.F. Frierson Jr. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer Prostate 49 2001 166 171
15. G.A. Calin, C.D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, and E. Noch Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 99 2002 15524 15529
16. R.I. Aqeilan, and G.A. Calin Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives Cell Death Differ 17 2010 215 220
17. G.A. Calin, A. Cimmino, M. Fabbri, M. Ferracin, S.E. Wojcik, and M. Shimizu MiR-15a and miR-16-1 cluster functions in human leukemia Proc Natl Acad Sci U S A 105 2008 5166 5171
18. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, and D. Peck MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
19. S. Deng, G.A. Calin, C.M. Croce, G. Coukos, and L. Zhang Mechanisms of microRNA deregulation in human cancer Cell Cycle 7 2008 2643 2646
20. S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, and F. Petrocca A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 103 2006 2257 2261
21. C. Xiao, L. Srinivasan, D.P. Calado, H.C. Patterson, B. Zhang, and J. Wang Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes Nat Immunol 9 2008 405 414
22. A. Rodriguez, E. Vigorito, S. Clare, M.V. Warren, P. Couttet, and D.R. Soond Requirement of bic/microRNA-155 for normal immune function Science 316 2007 608 611
23. S. Costinean, N. Zanesi, Y. Pekarsky, E. Tili, S. Volinia, and N. Heerema Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice Proc Natl Acad Sci U S A 103 2006 7024 7029
24. R.L. Skalsky, M.A. Samols, K.B. Plaisance, I.W. Boss, A. Riva, and M.C. Lopez Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155 J Virol 81 2007 12836 12845
25. Q. Yin, J. McBride, C. Fewell, M. Lacey, X. Wang, and Z. Lin MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways J Virol 82 2008 5295 5306
26. M. Gironella, M. Seux, M.J. Xie, C. Cano, R. Tomasini, and J. Gommeaux Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development Proc Natl Acad Sci U S A 104 2007 16170 16175
27. S. Jiang, H.W. Zhang, M.H. Lu, X.H. He, Y. Li, and H. Gu MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene Cancer Res 70 2010 3119 3127
28. M.V. Iorio, M. Ferracin, C.G. Liu, A. Veronese, R. Spizzo, and S. Sabbioni MicroRNA gene expression deregulation in human breast cancer Cancer Res 65 2005 7065 7070
29. P.P. Medina, M. Nolde, and F.J. Slack OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma Nature 467 2010 86 90
30. D.A. Guertin, and D.M. Sabatini An expanding role for mTOR in cancer Trends Mol Med 11 2005 353 361
31. M.V. Iorio, and C.M. Croce MicroRNAs in cancer: small molecules with a huge impact J Clin Oncol 27 2009 5848 5856
32. G.K. Scott, A. Goga, D. Bhaumik, C.E. Berger, C.S. Sullivan, and C.C. Benz Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b J Biol Chem 282 2007 1479 1486
33. L. Wu, and J.G. Belasco Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells Mol Cell Biol 25 2005 9198 9208
34. M. Zhou, Z. Liu, Y. Zhao, Y. Ding, H. Liu, and Y. Xi MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression J Biol Chem 285 2010 21496 21507
35. B. Shi, L. Sepp-Lorenzino, and M. Prisco Linsley P, deAngelis T, Baserga R. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells J Biol Chem 282 2007 32582 32590
36. M. Sachdeva, S. Zhu, F. Wu, H. Wu, V. Walia, and S. Kumar p53 represses c-Myc through induction of the tumor suppressor miR-145 Proc Natl Acad Sci U S A 106 2009 3207 3212
37. S.A. Melo, and M. Esteller Dysregulation of microRNAs in cancer: playing with fire FEBS Lett 585 2010 2087 2099
38. Y.S. Lee, and A. Dutta The tumor suppressor microRNA let-7 represses the HMGA2 oncogene Genes Dev 21 2007 1025 1030
39. S. Diederichs, and D.A. Haber Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing Cancer Res 66 2006 6097 6104
40. J. Krol, I. Loedige, and W. Filipowicz The widespread regulation of microRNA biogenesis, function and decay Nat Rev Genet. 11 2010 597 610
41. T.C. Chang, D. Yu, Y.S. Lee, E.A. Wentzel, D.E. Arking, and K.M. West Widespread microRNA repression by Myc contributes to tumorigenesis Nat Genet 40 2008 43 50
42. T.C. Chang, E.A. Wentzel, O.A. Kent, K. Ramachandran, M. Mullendore, and K.H. Lee Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis Mol Cell 26 2007 745 752
43. M.J. Bueno, I. Perez de Castro, M. Gomez de Cedron, J. Santos, G.A. Calin, and J.C. Cigudosa Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression Cancer Cell 13 2008 496 506
44. U. Lehmann, B. Hasemeier, M. Christgen, M. Muller, D. Romermann, and F. Langer Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer J Pathol 214 2008 17 24
45. A. Lujambio, S. Ropero, E. Ballestar, M.F. Fraga, C. Cerrato, and F. Setien Genetic unmasking of an epigenetically silenced microRNA in human cancer cells Cancer Res 67 2007 1424 1429
46. Y. Saito, G. Liang, G. Egger, J.M. Friedman, J.C. Chuang, and G.A. Coetzee Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Cancer cell 9 2006 435 443
47. B. Muralidhar, L.D. Goldstein, G. Ng, D.M. Winder, R.D. Palmer, and E.L. Gooding Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels J Pathol 212 2007 368 377
48. S. Chiosea, E. Jelezcova, U. Chandran, J. Luo, G. Mantha, and R.W. Sobol Overexpression of Dicer in precursor lesions of lung adenocarcinoma Cancer Res 67 2007 2345 2350
49. T. Nakamura, E. Canaani, and C.M. Croce Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing Proc Natl Acad Sci U S A 104 2007 10980 10985
50. C. Florean, M. Schnekenburger, C. Grandjenette, M. Dicato, and M. Diederich Epigenomics of leukemia: from mechanisms to therapeutic applications Epigenomics 3 2011 581 609
51. G.A. Calin, M. Ferracin, A. Cimmino, G. Di Leva, M. Shimizu, and S.E. Wojcik A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia N Engl J Med 353 2005 1793 1801
52. D.L. Zanette, F. Rivadavia, G.A. Molfetta, F.G. Barbuzano, R. Proto-Siqueira, and W.A. Silva-Jr miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia Braz J Med Biol Res 40 2007 1435 1440
53. S. Mi, J. Lu, M. Sun, Z. Li, H. Zhang, and M.B. Neilly MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia Proc Natl Acad Sci U S A 104 2007 19971 19976
54. E.M. Kroh, R.K. Parkin, P.S. Mitchell, and M. Tewari Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) Methods 50 2010 298 301
55. C.A. Andorfer, B.M. Necela, E.A. Thompson, and E.A. Perez MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer Trends Mol Med 17 2011 313 319
56. R. Garzon, G. Marcucci, and C.M. Croce Targeting microRNAs in cancer: rationale, strategies and challenges Nat Rev Drug Discov 9 2010 775 789
57. C.C. Esau Inhibition of microRNA with antisense oligonucleotides Methods 44 2008 55 60
58. W. Duan, J.H. Chan, K. McKay, J.R. Crosby, H.H. Choo, and B.P. Leung Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice Am J Respir Crit Care Med 171 2005 571 578
59. J. Krutzfeldt, S. Kuwajima, R. Braich, K.G. Rajeev, J. Pena, and T. Tuschl Specificity, duplex degradation and subcellular localization of antagomirs Nucleic Acids Res 35 2007 2885 2892
60. J.A. Broderick, and P.D. Zamore MicroRNA therapeutics Gene Ther 18 2011 1104 1110
61. J.M. Franco-Zorrilla, A. Valli, M. Todesco, I. Mateos, M.I. Puga, and I. Rubio-Somoza Target mimicry provides a new mechanism for regulation of microRNA activity Nat Genet 39 2007 1033 1037
62. A. Care, D. Catalucci, F. Felicetti, D. Bonci, A. Addario, and P. Gallo MicroRNA-133 controls cardiac hypertrophy Nat Med 13 2007 613 618
63. A.G. Bader, D. Brown, and M. Winkler The promise of microRNA replacement therapy Cancer Res 70 2010 7027 7030
64. M.F. Segura, D. Hanniford, S. Menendez, L. Reavie, X. Zou, and S. Alvarez-Diaz Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor Proc Natl Acad Sci U S A 106 2009 1814 1819
65. M.S. Ebert, and P.A. Sharp MicroRNA sponges: progress and possibilities RNA 16 2010 2043 2050
66. M. Schnekenburger, C. Grandjenette, J. Ghelfi, T. Karius, B. Foliguet, and M. Dicato Sustained exposure to the DNA demethylating agent, 2'-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy Biochem Pharmacol 81 2011 364 378
67. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the last 25 years J Nat Prod 70 2007 461 477
68. A. Duvoix, R. Blasius, S. Delhalle, M. Schnekenburger, F. Morceau, and E. Henry Chemopreventive and therapeutic effects of curcumin Cancer Lett 223 2005 181 190
69. R. Blasius, A. Duvoix, F. Morceau, M. Schnekenburger, S. Delhalle, and E. Henry Curcumin stability and its effect on glutathione S-transferase P1-1 mRNA expression in K562 cells Ann N Y Acad Sci 1030 2004 442 448
70. R. Wilken, M.S. Veena, M.B. Wang, and E.S. Srivatsan Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma Mol Cancer 10 2011 12
71. A. Duvoix, F. Morceau, S. Delhalle, M. Schmitz, M. Schnekenburger, and M.M. Galteau Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition Biochem Pharmacol 66 2003 1475 1483
72. M. Sun, Z. Estrov, Y. Ji, K.R. Coombes, D.H. Harris, and R. Kurzrock Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells Mol Cancer Ther 7 2008 464 473
73. J. Zhang, T. Zhang, X. Ti, J. Shi, C. Wu, and X. Ren Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway Biochem Biophys Res Commun 399 2010 1 6
74. J. Yang, Y. Cao, J. Sun, and Y. Zhang Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells Med Oncol 27 2010 1114 1118
75. S. Fu, and R. Kurzrock Development of curcumin as an epigenetic agent Cancer 116 2010 4670 4676
76. B. Bao, S. Ali, D. Kong, S.H. Sarkar, Z. Wang, and S. Banerjee Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer PLoS One 6 2011 e17850
77. G. Duester Retinoic acid synthesis and signaling during early organogenesis Cell 134 2008 921 931
78. K. Niederreither, and P. Dolle Retinoic acid in development: towards an integrated view Nat Rev Genet 9 2008 541 553
79. R. Garzon, F. Pichiorri, T. Palumbo, M. Visentini, R. Aqeilan, and A. Cimmino MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia Oncogene 26 2007 4148 4157
80. K.H. Lee, C. Lotterman, C. Karikari, N. Omura, G. Feldmann, and N. Habbe Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer Pancreatology 9 2009 293 301
81. C. Welch, Y. Chen, and R.L. Stallings MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells Oncogene 26 2007 5017 5022
82. F.U. Weiss, I.J. Marques, J.M. Woltering, D.H. Vlecken, A. Aghdassi, and L.I. Partecke Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer Gastroenterology 137 2009 2136-45 e1-e7
83. J.I. Ahn, K.J. Jeong, M.J. Ko, H.J. Shin, H.S. Kim, and H.J. Chung Changes of miRNA and mRNA expression in HepG2 cells treated by epigallocatechin gallate Mol Cell Toxicol 6 2010 169 177
84. F. Spinella, L. Rosano, V. Di Castro, S. Decandia, A. Albini, and M.R. Nicotra Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma Mol Cancer Ther 5 2006 1483 1492
85. W.P. Tsang, and T.T. Kwok Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells J Nutr Biochem 21 2010 140 146
86. I.A. Siddiqui, M. Asim, B.B. Hafeez, V.M. Adhami, R.S. Tarapore, and H. Mukhtar Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer FASEB J 25 2011 1198 1207
87. Y. Chen, M.S. Zaman, G. Deng, S. Majid, S. Saini, and J. Liu MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer Cancer Prev Res (Phila) 4 2011 76 86
88. Q. Sun, R. Cong, H. Yan, H. Gu, Y. Zeng, and N. Liu Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression Oncol Rep 22 2009 563 567
89. S. Majid, A.A. Dar, S. Saini, Y. Chen, V. Shahryari, and J. Liu Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer Cancer Res 70 2010 2809 2818
90. E. Tili, J.J. Michaille, H. Alder, S. Volinia, D. Delmas, and N. Latruffe Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in SW480 cells Biochem Pharmacol 80 2010 2057 2065
91. E. Tili, J.J. Michaille, B. Adair, H. Alder, E. Limagne, and C. Taccioli Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD Carcinogenesis 31 2010 1561 1566
92. S.D. Selcuklu, M.T. Donoghue, and C. Spillane miR-21 as a key regulator of oncogenic processes Biochem Soc Trans 37 2009 918 925
93. S.R. Chinni, Y. Li, S. Upadhyay, P.K. Koppolu, and F.H. Sarkar Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells Oncogene 20 2001 2927 2936
94. T. Melkamu, X. Zhang, J. Tan, Y. Zeng, and F. Kassie Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol Carcinogenesis 31 2010 252 258
95. A. Izzotti, G.A. Calin, P. Arrigo, V.E. Steele, C.M. Croce, and S. De Flora Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke FASEB J 23 2009 806 812
96. Y. Li, T.G. VandenBoom 2nd, D. Kong, Z. Wang, S. Ali, and P.A. Philip Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells Cancer Res 69 2009 6704 6712
97. M. Schnekenburger, F. Morceau, E. Henry, R. Blasius, M. Dicato, and C. Trentesaux Transcriptional and post-transcriptional regulation of glutathione S-transferase P1 expression during butyric acid-induced differentiation of K562 cells Leuk Res 30 2006 561 568
98. S.J. Miller Cellular and physiological effects of short-chain fatty acids Mini Rev Med Chem 4 2004 839 845
99. S. Hu, T.S. Dong, S.R. Dalal, F. Wu, M. Bissonnette, and J.H. Kwon The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer PLoS One 6 2011 e16221
100. C.D. Davis, and S.A. Ross Evidence for dietary regulation of microRNA expression in cancer cells Nutr Rev 66 2008 477 482